Form 4: Organon & Co. Director Carrie Smith Cox Acquires Shares
SEC Form 4
Director Carrie Smith Cox purchased 12,469 shares of Organon & Co. common stock at a weighted average price of $8.0673 on May 14, 2025.
Summary
- On May 14, 2025, Carrie Smith Cox, a director of Organon & Co., acquired 12,469 shares of common stock.
- The shares were purchased at a weighted average price of $8.0673.
- The transactions occurred at prices ranging from $8.059 to $8.07.
- Following the transaction, Ms. Cox directly owns 12,469 shares of Organon & Co.
Sentiment
Score: 6
Explanation: A director purchasing shares is generally a positive sign, but the scale of the purchase is relatively small and may not have a significant impact on overall sentiment.
Positives
- A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
Insider transactions are closely monitored by investors as they can provide insights into management's perspective on the company's valuation and future performance. Director purchases are generally viewed more favorably than sales.
Key Dates
| Date | Description |
|---|---|
| 05/14/2025 | Date of transaction: Carrie Smith Cox purchased shares of Organon & Co. |
| 05/15/2025 | Date of signature: Form 4 signed by Faye C. Brown, as Attorney-in-Fact for Carrie Smith Cox |
Keywords
Organon & Co., Director, Share Purchase, Carrie Smith Cox, OGN, Common Stock, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.